Bristol-Myers Pharmaceuticals

Bristol-Myers Squibb House, Uxbridge Business Park, Sanderson Road, Uxbridge, Middlesex, UB8 1DH , UK
Telephone: +44 (0)1895 52 3000
Fax: +44 (0)1895 52 3010
Medical Information Direct Line: +44 (0)1895 523 740
Medical Information e-mail: medical.information@bms.com
Medical Information Fax: +44 (0)1895 523 677
Summary of Product Characteristics last updated on the eMC: 25/09/2009
SPC Questran & Questran Light

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 25/09/2009 and displayed until Current
Reasons for adding or updating:
  • Change to section 1 -Name of the Medicinal product
  • Change to section 3 - Pharmaceutical form
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   17-Mar-2009
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Section 1: Name change in line with guidelines.
Section 3: Change to - 'Powder for Oral Suspension'
Section 10: Change to date of revision following variation approval
Updated on 14/09/2005 and displayed until 25/09/2009
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
  • Change to section 10 (date of (partial) revision of the text
Updated on 22/02/2005 and displayed until 14/09/2005
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 23/04/2004 and displayed until 22/02/2005
Reasons for adding or updating:
  • Change from the BAN of the active substance to the rINN
Updated on 29/04/2003 and displayed until 23/04/2004
Reasons for adding or updating:
  • Change to section 4.4 - Special Warnings and Precautions for Use
  • Change to section 9 - Date of Renewal of Authorisation
  • Change to section 10 (date of (partial) revision of the text
Updated on 22/08/2001 and displayed until 29/04/2003
Reasons for adding or updating:
  • Change to section 6.1 - List of Excipients
  • Change to section 6. 5 - Nature and Contents of Container
  • Change to section 10 (date of (partial) revision of the text
Updated on 10/02/2000 and displayed until 22/08/2001
Reasons for adding or updating:
  • No reasons supplied
Updated on 06/09/1999 and displayed until 10/02/2000
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   colestyramine


© 2010 Datapharm Communications Ltd

Go to www.medicines.org.uk